[Treatment and prevention of recurrence of duodenal ulcer with pirenzepin and cimetidine].
Eichenberger Pm, Michael Giger, W Mattle, S Pelloni, S A Müller-Lissner, Gonvers Jj, R Birchler, A L Blum
Abstract
Eichenberger Pm, Michael Giger, W Mattle, S Pelloni, S A Müller-Lissner, Gonvers Jj, R Birchler, A L Blum
Abstract
The effect of pirenzepine and cimetidine on healing, symptoms, and relapse rate of duodenal ulcer was studied in a placebo controlled double blind trial. With regard to symptoms, cimetidine (1 g daily) was superior at the beginning of therapy to a low dose of pirenzepine (75 mg daily) and to placebo. No significant differences in ulcer healing were found between the 3 treatment groups. The relapse rate after treatment with pirenzepine was lower than after treatment with cimetidine.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effect of pirenzepine and cimetidine on healing, symptoms, and relapse rate of duodenal ulcer was studied in a placebo controlled double blind trial. With regard to symptoms, cimetidine (1 g daily) was superior at the beginning of therapy to a low dose of pirenzepine (75 mg daily) and to placebo. No significant differences in ulcer healing were found between the 3 treatment groups. The relapse rate after treatment with pirenzepine was lower than after treatment with cimetidine.
Key concepts: Cimetidine, Pirenzepine, Medicine, Placebo, Duodenal ulcer, Gastroenterology, Internal medicine, Chemotherapy